Showing results (221-230 of 254) with videos related to
Sort By:
Pageof 26
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2021
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-CVelia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, et al.The Journal of Antimicrobial Chemotherapy|August 11, 2020
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimenAdolfo de Salazar, Julia Dietz, Velia Chiara di Maio, et al.Journal of Global Antimicrobial Resistance|August 18, 2016
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitroClaudia Alteri, Matteo Surdo, Velia Chiara Di Maio, et al.The Journal of Pediatrics|January 18, 2024
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV CureAude Christelle Ka'e, Maria Mercedes Santoro, Aubin Nanfack, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2023
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replicationRomina Salpini, Lorenzo Piermatteo, Giulia Torre, et al.Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Daniele Di Paolo, Domenico Di Carlo, et al.Viruses|July 11, 2018
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological TargetsLuna Colagrossi, Romina Salpini, Rossana Scutari, et al.Viruses|January 25, 2025
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income CountriesAlex Durand Nka, Yagai Bouba, Wilfried Rooker Tsapi Lontsi, et al.Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.Pageof 26